Back

MELD-albumin score is strongly associated with all-cause mortality in patients with acute myocardial infarction complicated by cardiogenic shock

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Optimising the management of cardiogenic shock Cardiogenic Shock ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Zakaria Alaoui-Ismaili

Nordsjaellands Hospital, Hilleroed (Denmark)

8 More presentations in this session

Presentation thumbnail
Diastolic shock index: a novel prognostic parameter unveiling insights into vasodilatory cardiogenic shock
Doctor M. Paiva (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Mechanical right ventricular involvement is independent of right coronary arterial bed and has a prognostic impact in acute myocardial infarction complicated by cardiogenic shock.
Doctor R. Espinosa-Soto (Ciudad de Mexico, MX)
Abstract Slides Video
Presentation thumbnail
Cardiogenic shock is more prevalent in racialised and newcomer populations and associated with higher mortality
Doctor D. Brahmbhatt (Toronto, CA)
Abstract Slides Video
Presentation thumbnail
Procedural volume and outcomes in patients with cardiogenic shock who received Impella: insight from the J-PVAD Registry
Doctor Y. Nishimoto (Toyonaka, JP)
Abstract Slides Video
Presentation thumbnail
Association between cardiogenic shock phenotype, vasopressor requirements and mortality
Doctor D. Sarma (Nashville, US)
Abstract Slides Video

Access the full session

Session thumbnail
Optimising the management of cardiogenic shock

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
An examination of co-existence of metabolic dysfunction-associated liver disease and chronic kidney disease and its effect on long-term mortality in patients with acute myocardial infarction
thumbnail
Congress Presentation
Outcome of patients with cardiogenic shock in acute myocardial infarction treated with Impella CP and a standardized protocol
thumbnail
Congress Presentation
Novel scoring system specific for patients treated with micro-axial percutaneous left ventricular assist device

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources